GSK to pay $300M to license drug it sees as potential lupus treatment

The deal with China’s Chimagen Biosciences is the latest example of pharma interest in exploring the potential of “T cell engagers” in autoimmune disease.

Cobalt mine in DRC poisoning communities, displacing thousands – Report – EnviroNews

March 10, 2026

Middle East conflict: World Water Council condemns attacks on water facilities, reiterates obligations under international law – EnviroNews

March 10, 2026

Source link

GSK to pay $300M to license drug it sees as potential lupus treatment

Cobalt mine in DRC poisoning communities, displacing thousands – Report – EnviroNews

Middle East conflict: World Water Council condemns attacks on water facilities, reiterates obligations under international law – EnviroNews

Artists Kim Schoen and Kim Schoenstadt make light of mistaken identities in collaborative show

UK Royal Navy to Renovate Merlin Helicopter Fleet Base in Cornwall

UK Royal Navy to Renovate Merlin Helicopter Fleet Base in Cornwall

Leave a Reply Cancel reply

RECOMMENDED NEWS

7 Tips to Maximize Mentor Relationships in Business

Embraer Starts Assembling Austria’s First C-390 Aircraft

Singapore Warns That Vulnerabilities Span the Entire Space Value Chain

Why is 3/20 So Important for Investors?

POPULAR NEWS

Mahama attends Liberia’s 178th independence anniversary

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

GSK to pay $300M to license drug it sees as potential lupus treatment

Related posts

Artists Kim Schoen and Kim Schoenstadt make light of mistaken identities in collaborative show

UK Royal Navy to Renovate Merlin Helicopter Fleet Base in Cornwall

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS